An interventional study of Prokinetic Motility Agents as primpiram and gastreg in Prokinetic Use After Emergency Intestinal Anastomosis, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-03.
Sponsored by Sohag University · Not applicable, Interventional, and Other
Prokinetic drugs used to accelerate healing of intestinal anastomosis of urgent cases which not prepared preoperative by increase intestinal motility and gastric emptying and decrease postoperative adhesions They are many types of prokinetics as cholinergic agonists, dopamine antagonist, serotonergic agonists and macrolides Agents of prokinetics administered immediately post operation and at the time of hospitalization
By evaluation the effect of prokinetic use versus non use after emergency intestinal intestinal anastomosis on short and long term clinical outcome It will be prospective cohort study which conducted in sohag university hospital Study will include patients presented with urgent anastomosis Inclusion criteria: all adults underwent emergency intestinal anastomosis Exclusion criteria: pediatrics, patients with comorbidities and patients with electively resection and anastomosis.
Primary goals are to detect effect of prokinetics on incidence of leakage rate Secondary outcomes include early bowel opening, enteral feeding, post operative pain, wound infection and adhesion formation rate.
1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.
This study's planned enrollment of 15 is below the median of 145 across 931 interventional studies indexed under Emergencies.
Browse Emergencies studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Prikinetic agents administered immediately post operative and time of stay at hospital twice daily
Drug: Prokinetic Motility Agents as primpiram and gastreg
Prospective cohort study to evaluate the effect of pro kinetic use in emergency intestinal anastomosis
Also known as: Primpiram and gastreg and erythromycin
Leakage rate
Fecal fistula
Time frame: 5 days postoperative
Early bowel opening
Duration taken to patient to pass feces and flatus
Time frame: 3 days postoperative
Plan to share: Yes — Evaluate the use of prokinetic versus non use in emergency intestinal anastomosis
Supporting information: Study protocol
This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University